Healthcare provider profile · identity verified

David Lundstedt Griffith, MD

Family Practice · SAN JOSE, CA · NPI 1790710903

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	531	170
Levothyroxine Sodium	Levothyroxine Sodium	337	98
Amlodipine Besylate	Amlodipine Besylate	237	83
Tamsulosin Hcl	Tamsulosin Hcl	231	78
Gabapentin	Gabapentin	213	69
Losartan Potassium	Losartan Potassium	202	63
Simvastatin	Simvastatin	153	47
Metformin Hcl	Metformin Hcl	131	43
Trazodone Hcl	Trazodone Hcl	131	41
Lisinopril	Lisinopril	115	37
Meloxicam	Meloxicam	108	41
Hydrochlorothiazide	Hydrochlorothiazide	105	36
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	97	27
Finasteride	Finasteride	95	30
Metoprolol Succinate	Metoprolol Succinate	95	32
Allopurinol	Allopurinol	93	28
Omeprazole	Omeprazole	93	29
Valsartan	Valsartan	91	25
Sertraline Hcl	Sertraline Hcl	85	25
Rosuvastatin Calcium	Rosuvastatin Calcium	84	29
Citalopram Hbr	Citalopram Hydrobromide	82	25
Metformin Hcl Er	Metformin Hcl	80	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	25
Alendronate Sodium	Alendronate Sodium	74	23
Eliquis	Apixaban	74	17
Famotidine	Famotidine	73	37
Pravastatin Sodium	Pravastatin Sodium	72	21
Lovastatin	Lovastatin	67	20
Escitalopram Oxalate	Escitalopram Oxalate	65	17
Celecoxib	Celecoxib	59	21
Memantine Hcl	Memantine Hcl	56	13
Pantoprazole Sodium	Pantoprazole Sodium	54	18
Mirtazapine	Mirtazapine	52	12
Ozempic	Semaglutide	52	14
Atenolol	Atenolol	49	16
Alprazolam	Alprazolam	45	13
Metoprolol Tartrate	Metoprolol Tartrate	45	16
Dutasteride	Dutasteride	43	12
Nortriptyline Hcl	Nortriptyline Hcl	43	12
Diclofenac Sodium	Diclofenac Sodium	41	14
Prednisone	Prednisone	40	32
Zolpidem Tartrate	Zolpidem Tartrate	40	13
Fluoxetine Hcl	Fluoxetine Hcl	36	12
Furosemide	Furosemide	36	suppressed
Spironolactone	Spironolactone	36	12
Synthroid	Levothyroxine Sodium	36	11
Albuterol Sulfate Hfa	Albuterol Sulfate	35	21
Azithromycin	Azithromycin	33	33
Glipizide	Glipizide	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	11
Bupropion Xl	Bupropion Hcl	29	suppressed
Ibuprofen	Ibuprofen	29	17
Donepezil Hcl	Donepezil Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	19
Olanzapine	Olanzapine	27	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Clonazepam	Clonazepam	24	11
Jardiance	Empagliflozin	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	16
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Colchicine	Colchicine	18	suppressed
Hydrocortisone	Hydrocortisone	18	12
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Amoxicillin	Amoxicillin	17	14
Doxycycline Hyclate	Doxycycline Hyclate	17	14
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Lorazepam	Lorazepam	17	12
Misoprostol	Misoprostol	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Temazepam	Temazepam	16	suppressed
Naproxen	Naproxen	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Cefadroxil	Cefadroxil	14	11
Farxiga	Dapagliflozin Propanediol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Glimepiride	Glimepiride	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Ramipril	Ramipril	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error